Redcare Pharmacy N.V. (SAEYY) Stock Price & Analysis
Redcare Pharmacy N.V. (SAEYY) — price $7.79 (0.00%), as of the Nov 19, 2026 trading session; market cap $1.57B.
Educational signal · not a buy or sell recommendation · How to read this
Redcare Pharmacy N.V. · SAEYY
Redcare Pharmacy NV is a European online pharmacy operating in multiple countries, including Germany and the Netherlands. The company offers prescription and over-the-counter medications, along with beauty and personal care products.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $7.79 | |
| Change on the day | 0.00% | |
| 52-week range | $3.59 – $9.36 | |
| Market capitalisation | $1.57B | |
| Shares traded on the day | 100 |
Price & events
Other perspectives
Council score for Redcare Pharmacy (SAEYY): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 7, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Apr 29, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Apr 29, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Redcare Pharmacy (SAEYY), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Redcare Pharmacy N.V. (SAEYY) is the company analyzed here. It employs 1,827 people and is led by Peter Linstow. In Q3 FY2026 it reported revenue of €847M and net income of €800,000. The market values it at $1.57B.
What do the latest results show for Redcare Pharmacy (SAEYY)?
Short answer · as of
The most recent reported quarter, Q3 FY2026, carried revenue of €847M.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2026 | €847M | €800,000 | €0.0040 (diluted) |
| Q2 FY2026 | €854M | €5M | €0.02 (diluted) |
| Q1 FY2026 | €863M | -€11M | -€0.05 (diluted) |
| Q4 FY2025 | €788M | -€29M | -€0.14 (diluted) |
What are the financial strengths and risks for Redcare Pharmacy (SAEYY)?
Short answer · as of
The distress and quality screens read Altman Z 4.03 · Piotroski F 3. Trailing ratios: ROE -7.5% · ROA -2.9% · current ratio 1.62 · earnings yield -2.5% · free-cash-flow yield -2.3%.
Data-derived red flags
- Negative return on equity (-7.5%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held SAEYY in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported SAEYY in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What Investors Ask About Redcare Pharmacy (SAEYY)
These answers are editorial: 1 of these 8 answers is drawn from the SAEYY research dossier (written Mar 16, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is SAEYY a good stock to buy?
Stock Expert AI does not rate SAEYY buy, sell or hold. Redcare Pharmacy N.V. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the SAEYY stock price today?
The last price recorded for Redcare Pharmacy N.V. (SAEYY), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What does Redcare Pharmacy NV do?
Redcare Pharmacy NV operates as an online pharmacy business, primarily serving customers in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France.
What are the key factors to evaluate for SAEYY?
Evaluate SAEYY on fundamentals, analyst consensus, and risk factors. By offering these value-added services, the company can attract new customers and enhance customer loyalty. Not financial advice.
How frequently does SAEYY data refresh on this page?
SAEYY's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven SAEYY's recent stock price performance?
Redcare Pharmacy N.V. (SAEYY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established online presence in multiple European countries. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SAEYY overvalued or undervalued right now?
Redcare Pharmacy N.V. (SAEYY) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research SAEYY before investing?
Before investing in Redcare Pharmacy N.V. (SAEYY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 13 figures on this page — 8 from Financial Modeling Prep (FMP) and 5 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com